BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 7821738)

  • 1. The beta cell in NIDDM: giving light to the blind.
    Malaisse WJ
    Diabetologia; 1994 Sep; 37 Suppl 2():S36-42. PubMed ID: 7821738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiology and pathology of islet metabolism.
    Malaisse WJ
    Diabete Metab; 1994; 20(2):95-8. PubMed ID: 7805957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of leptin receptors in pancreatic islets of Zucker diabetic fatty rats restores GLUT-2, glucokinase, and glucose-stimulated insulin secretion.
    Wang MY; Koyama K; Shimabukuro M; Mangelsdorf D; Newgard CB; Unger RH
    Proc Natl Acad Sci U S A; 1998 Sep; 95(20):11921-6. PubMed ID: 9751766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta cell dysfunction in non-insulin-dependent diabetes mellitus.
    Gray H; O'Rahilly S
    Transplant Proc; 1994 Apr; 26(2):366-70. PubMed ID: 8171465
    [No Abstract]   [Full Text] [Related]  

  • 5. GLUT2 expression and function in beta-cells of GK rats with NIDDM. Dissociation between reductions in glucose transport and glucose-stimulated insulin secretion.
    Ohneda M; Johnson JH; Inman LR; Chen L; Suzuki K; Goto Y; Alam T; Ravazzola M; Orci L; Unger RH
    Diabetes; 1993 Jul; 42(7):1065-72. PubMed ID: 8513973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of glucose transporter-2, glucokinase and mitochondrial glycerolphosphate dehydrogenase in pancreatic islets during rat ontogenesis.
    García-Flores M; Zueco JA; Arenas J; Blázquez E
    Eur J Biochem; 2002 Jan; 269(1):119-27. PubMed ID: 11784305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lilly Lecture 1994. The beta-cell in diabetes: from molecular genetics to clinical research.
    Polonsky KS
    Diabetes; 1995 Jun; 44(6):705-17. PubMed ID: 7789637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiology, pathology and pharmacology of insulin secretion: recent acquisitions.
    Malaisse WJ
    Diabetes Metab; 1997 Sep; 23 Suppl 3():6-15. PubMed ID: 9342537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High glucose-induced impairment in insulin secretion is associated with reduction in islet glucokinase in a mouse model of susceptibility to islet dysfunction.
    Kooptiwut S; Kebede M; Zraika S; Visinoni S; Aston-Mourney K; Favaloro J; Tikellis C; Thomas MC; Forbes JM; Cooper ME; Dunlop M; Proietto J; Andrikopoulos S
    J Mol Endocrinol; 2005 Aug; 35(1):39-48. PubMed ID: 16087720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of pancreatic B-cell dysfunction and glucose toxicity in non-insulin-dependent diabetes.
    Flatt PR; Barnett CR; Swanston-Flatt SK
    Biochem Soc Trans; 1994 Feb; 22(1):18-23. PubMed ID: 8206220
    [No Abstract]   [Full Text] [Related]  

  • 11. Underexpression of beta cell high Km glucose transporters in noninsulin-dependent diabetes.
    Johnson JH; Ogawa A; Chen L; Orci L; Newgard CB; Alam T; Unger RH
    Science; 1990 Oct; 250(4980):546-9. PubMed ID: 2237405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiologic relevance of heterogeneity in the pancreatic beta-cell population.
    Pipeleers D; Kiekens R; Ling Z; Wilikens A; Schuit F
    Diabetologia; 1994 Sep; 37 Suppl 2():S57-64. PubMed ID: 7821741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pathogenesis of NIDDM.
    Hales CN
    Diabetologia; 1994 Sep; 37 Suppl 2():S162-8. PubMed ID: 7821732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central nervous system and peripheral abnormalities: clues to the understanding of obesity and NIDDM.
    Jeanrenaud B
    Diabetologia; 1994 Sep; 37 Suppl 2():S170-8. PubMed ID: 7821733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation, perturbation, and correction of metabolic events in pancreatic islets.
    Malaisse WJ
    Acta Diabetol; 1996 Sep; 33(3):173-9. PubMed ID: 8904921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-cell GLUT-2 loss and non-insulin-dependent diabetes mellitus: current status of the hypothesis.
    Milburn JL; Ohneda M; Johnson JH; Unger RH
    Diabetes Metab Rev; 1993 Oct; 9(3):231-6. PubMed ID: 8187609
    [No Abstract]   [Full Text] [Related]  

  • 17. Perturbation of islet metabolism and insulin release in NIDDM.
    Malaisse WJ
    Adv Exp Med Biol; 1993; 334():13-23. PubMed ID: 8249679
    [No Abstract]   [Full Text] [Related]  

  • 18. Pancreatic islet GLUT2 glucose transporter mRNA and protein expression in humans with and without NIDDM.
    Ferrer J; Benito C; Gomis R
    Diabetes; 1995 Dec; 44(12):1369-74. PubMed ID: 7589840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FAD-linked glycerophosphate dehydrogenase deficiency in pancreatic islets of mice with hereditary diabetes.
    Sener A; Herberg L; Malaisse WJ
    FEBS Lett; 1993 Feb; 316(3):224-7. PubMed ID: 8422947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early diabetes and abnormal postnatal pancreatic islet development in mice lacking Glut-2.
    Guillam MT; Hümmler E; Schaerer E; Yeh JI; Birnbaum MJ; Beermann F; Schmidt A; Dériaz N; Thorens B
    Nat Genet; 1997 Nov; 17(3):327-30. PubMed ID: 9354799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.